GALECTIN THERAPEUTICS INC
GALT—
GALECTIN THERAPEUTICS INCGALT$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-0.48
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
—
Net income
$-30.84M
Net margin
—
Gross margin
—
Dividends & financials
GALECTIN THERAPEUTICS INC (GALT) reported revenue of — and net income of $-30.84M, or $-0.48 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.